IVA Stock Analysis: Buy, Sell, or Hold?

IVA - Inventiva S.A. American Depository Shares

Pharmaceutical Preparations
$4.68
0.03 (0.65%) ▲
5d: +1.74%
30d: +3.77%
90d: -10.17%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 25, 2026

Get Alerted When IVA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: IVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IVA is currently trading at $4.68, which is considered fair relative to its 30-day fair value range of $4.41 to $4.69.

Technical Outlook: Technically, IVA is in a downtrend. Immediate support is located at $4.45, while resistance sits at $4.88.

Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.88 (+218.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.41 - $4.69
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (44/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 218.0% below Wall St target ($14.88)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $4.41 - $4.69
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $4.45
Resistance Level $4.88
Current Trend Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -5.62
Wall Street Target $14.88 (+218.0%)
Revenue Growth (YoY) -89.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 7:56 AM ET
Data refreshes hourly during market hours. Next update: 8:56 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IVA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 58 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$53 57 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$92 54 HOLD
RCKT
Rocket Pharmaceuticals Iâ€Ļ
STRONG BUY
18 analysts
$9 53 HOLD

More Analysis for IVA

IVA Technical Chart IVA Price Prediction IVA Earnings Date IVA Investment Advisor IVA Fair Price Analyzer IVA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals